Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA and Korean Ministry of Food and Drug Safety to share confidential COVID-19 information 30 June 2020NewsHumanCOVID-19Medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2020 26 June 2020NewsHumanCOVID-19BiosimilarsGeneric and hybrid medicinesMedicines New treatment to enable kidney transplant in highly sensitised patients 26 June 2020Press releaseHumanMedicines New medicine for cystic fibrosis patients 26 June 2020Press releaseHumanMedicines First COVID-19 treatment recommended for EU authorisation 25 June 2020Press releaseHumanCOVID-19Medicines Emer Cooke nominated as new EMA Executive Director 25 June 2020Press releaseCorporateGovernance Global regulators discuss data requirements for phase 3 trials of COVID-19 vaccines 24 June 2020Press releaseHumanCOVID-19Clinical trials European regulators make recommendations drawing on lessons learnt from presence of nitrosamines in sartan medicines 23 June 2020Press releaseHumanReferrals Academia developing medicines for rare diseases to receive free EMA scientific advice 23 June 2020NewsHumanRare diseases European Commission, EMA and FDA agree new priorities to strengthen their collaboration on medicines 22 June 2020NewsHumanCOVID-19 1 … 79 80 81 82 83 Page 83 of 380 84 85 86 87 … 380
EMA and Korean Ministry of Food and Drug Safety to share confidential COVID-19 information 30 June 2020NewsHumanCOVID-19Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2020 26 June 2020NewsHumanCOVID-19BiosimilarsGeneric and hybrid medicinesMedicines
New treatment to enable kidney transplant in highly sensitised patients 26 June 2020Press releaseHumanMedicines
First COVID-19 treatment recommended for EU authorisation 25 June 2020Press releaseHumanCOVID-19Medicines
Global regulators discuss data requirements for phase 3 trials of COVID-19 vaccines 24 June 2020Press releaseHumanCOVID-19Clinical trials
European regulators make recommendations drawing on lessons learnt from presence of nitrosamines in sartan medicines 23 June 2020Press releaseHumanReferrals
Academia developing medicines for rare diseases to receive free EMA scientific advice 23 June 2020NewsHumanRare diseases
European Commission, EMA and FDA agree new priorities to strengthen their collaboration on medicines 22 June 2020NewsHumanCOVID-19